Renaissance Cell Technologies

Renaissance Cell Technologies is a biotechnology company specializing in the development of induced pluripotent stem cell (iPSC) technologies. Founded in 2016 by stem cell pioneer Dr. James Thomson, the company focused on advancing the science of cell reprogramming and differentiation. The firm provided high-quality, standardized human cells to the pharmaceutical industry for use in drug discovery, toxicity testing, and disease modeling. Its proprietary methods aimed to improve the efficiency and scalability of producing various functional cell types from pluripotent sources. In January 2019, the company was acquired by Fujifilm Cellular Dynamics to bolster its intellectual property portfolio and R&D capabilities in the regenerative medicine field.